Karyotyping

← Back to Index (🧬 Genetics)

Definition And Core Concepts

Methodology And Procedure

Clinical Indications

Category Specific Indications
Suspected Aneuploidy Syndromes Clinical features of Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), Patau syndrome (Trisomy 13), Turner syndrome (45,X), or Klinefelter syndrome (47,XXY).
Pediatric And Developmental Multiple congenital anomalies, dysmorphic features, unexplained global developmental delay or intellectual disability.
Reproductive And Endocrine Ambiguous genitalia, disorders of sexual differentiation, primary amenorrhea, and infertility.
Family History Recurrent pregnancy losses (≥ 3), history of stillbirths/neonatal deaths, or family history of balanced structural chromosomal rearrangements.
Oncology Surveillance for specific solid tumors and leukemias (e.g., Philadelphia chromosome) via bone marrow aspirates.
Prenatal Testing Advanced maternal age, abnormal non-invasive prenatal testing (NIPT), or abnormal fetal ultrasound findings.

Cytogenetic Nomenclature

Symbol/Abbreviation Definition Clinical Example
+ / - Gain or loss of a whole chromosome 47,XX,+21 (Female with Trisomy 21)
del Deletion of a chromosome segment 46,XY,del(5p) (Male with Cri-du-chat syndrome)
t Translocation (exchange between chromosomes) t(2;8)(q33;q24.1) (Reciprocal translocation)
inv Inversion of a chromosome segment 46,XY,inv(2)(p21q31) (Pericentric inversion)
mos / / Mosaicism (presence of distinct cell lines) mos 45,X/46,XX (Turner syndrome mosaicism)

Advantages And Limitations

Feature Advantages Limitations
Diagnostic Capabilities Gold standard for identifying balanced structural rearrangements (reciprocal translocations, Robertsonian translocations, inversions) missed by Chromosomal Microarray (CMA). Low resolution limit of 5-10 Mb. Cannot detect microdeletions, microduplications, single-gene point mutations, or epigenetic changes.
Tissue Requirements Allows direct visual confirmation of the entire chromosomal complement. Strictly requires actively dividing cells; culture failure occurs in 5-10% of samples.
Turnaround And Cost Low cost and widely available. Time-consuming process requiring 7-14 days compared to rapid molecular methods.
Mosaicism Detection Evaluates multiple cell lines systematically. May fail to detect low-level somatic mosaicism (typically less than 10-15%).